Dianthus Therapeutics Inc (DNTH) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Dianthus Therapeutics Inc   (NASDAQ: DNTH)


Dianthus Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Dianthus Therapeutics Inc's ROI in the second quarter of 2026?
Dianthus Therapeutics Inc recorded a cumulative net loss of $-192 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -22.35%.

Within the Healthcare sector 322 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3799 to 4203.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 158.34 % 85.42 % 18.57 % 24.74 % 23.21 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,179 1,208 500 554 306
Return On Investment (TTM) -22.35 % -27.06 % -38.39 % -32.67 % -34.47 %
DNTH's Overall Ranking # 4203 # 3799 # 3265 # 3309 # 3145
Seq. Investment Change TTM 34 % 51.79 % 9.35 % 16.15 % -3.82 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -192 -174 -162 -126 -115

DNTH Company Profile >> Back to DNTH Roi Comparisons >> See Annual DNTH Return On Investment



Return On Investment DNTH's Ranking
Within: No.
Industry # 118
Sector # 323
Overall # 4203

Return On Investment Statistics
High Average Low
-15.71 %
-57.65 %
-428.24 %
(Jun 30 2024)   (Sep 30 2023)







Financial Statements
Dianthus Therapeutics Inc's II. Quarter Investments $ 1,179 Millions DNTH's Balance sheet
Dianthus Therapeutics Inc's II. Quarter Income $ -50 Millions Quarterly DNTH's Income Statement
DNTH's Income by Division See DNTH's Income by Division


DNTH Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 500 356 170 132 179
Y / Y Investment Growth 40.68 % 109.43 % 28.52 % -26.23 % 19.23 %
Net Income in Millions -162 -85 -44 -76 -71
Y / Y Net Income Growth - - - - -
Annual Return On Investment -32.46 % -23.9 % -25.65 % -57.88 % -39.73 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DNTH's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DNTH's Competitors
Subscribers only: Roi for Dianthus Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for DNTH's Customers

Other Ratios
DNTH's Roa DNTH's Inventory Turnover Ratio DNTH's Growth Rates DNTH's Dividend Statistics
DNTH's Profitability Ratios DNTH's Asset Turnover Ratio DNTH's Dividend Growth
DNTH's Roe DNTH's Valuation Ratios DNTH's Financial Strength Ratios DNTH's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:34:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.